← back to search

Rafael Díaz

Instituto Cardiovascular de Rosario ·
Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies, and Acute Myocardial Infarction Research.
h-index
16
citations
12,319
works
39
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction
JACC Heart Failure 2024cited by 23position: middledoi
Impact of Complete Revascularization in the ISCHEMIA Trial
Journal of the American College of Cardiology 2023cited by 44position: middledoi
Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial
JACC Heart Failure 2023cited by 26position: middledoi
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure
JAMA Cardiology 2021cited by 104position: middledoi
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF
Journal of the American College of Cardiology 2021cited by 102position: middledoi
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
New England Journal of Medicine 2020cited by 637position: middledoi
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction
JACC Heart Failure 2020cited by 141position: middledoi
Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction: GALACTIC-HF Baseline Characteristics and Comparison with Contemporary Clinical Trials
European Journal of Heart Failure 2020cited by 64position: middledoi
Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial
European Heart Journal 2013cited by 243position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John R. Teerlink · University of Glasgow5 papers (2020–2024)G. Michael Felker · Duke University5 papers (2020–2024)John J.V. McMurray · University of Glasgow5 papers (2020–2024)Marco Metra · Mylan (South Africa)5 papers (2020–2024)Scott D. Solomon · Harvard University5 papers (2020–2024)Fady I. Malik · Jena University Hospital5 papers (2020–2024)Brian Claggett · Harvard University4 papers (2021–2024)Stephen B. Heitner · Brigham and Women's Hospital3 papers (2021–2024)Stuart Kupfer · Brigham and Women's Hospital3 papers (2021–2024)Eva Gonçalvesová · National Institute of Cardiovascular Diseases2 papers (2021–2023)María G. Crespo‐Leiro · Universidade da Coruña2 papers (2021–2023)Eileen O’Meara · Montreal Heart Institute2 papers (2021–2023)Mayanna Lund · Middlemore Hospital2 papers (2021–2023)Diana Bonderman · SBA Research2 papers (2021–2023)Tor Biering‐Sørensen · University of Copenhagen2 papers (2021–2024)Siddique Abbasi · Amgen (United States)2 papers (2021–2021)Jose H. Flores‐Arredondo · Amgen (United States)1 papers (2021–2021)Jonathan G. Howlett · Calgary Laboratory Services1 papers (2021–2021)Punag Divanji · The University of Texas Southwestern Medical Center1 papers (2024–2024)Inder S. Anand · University of Minnesota1 papers (2021–2021)